Clinical and public health
A frontline filter before the scan
IMUCEL is designed to help GPs, screening programmes, and health systems decide who needs imaging first.
The triage imperative
Clinicians lack a fast way to rank risk
Today most patients enter the same queue, because there is no quick, objective way to stratify risk before ordering scans. A rapid urine rule-in changes that.
Where it fits
Three roles in the care pathway
GP frontline triage
An immediate rule-in filter for vague symptoms during a routine consultation, replacing wait-and-see delays.
Unclogging imaging queues
Fast-tracks bio-signal-positive patients to CT, PET, or MRI, easing public health waiting lists.
Pre-screening priority
Flags high-risk cases before mammography and helps tell benign masses from malignant ones.
How triage works
From symptom to the right next step
-
1
Rapid urine test
The patient gives a urine sample in clinic. The rule-in result is ready in under 15 minutes.
-
2
Positive result
A positive bio-signal fast-tracks the patient to expedited imaging, often within 48 hours.
-
3
Negative result
A negative result supports routine care, sparing scarce scanner slots for those who need them.
New screening opportunities
Reaching cohorts standard screening misses
Women under 40 and dense breast tissue
A urine bio-signal can screen younger or higher-risk women without relying on mammography, sidestepping the limits of dense breast tissue.
Senior populations
A low-cost pan-cancer urine test enables routine surveillance for older adults, the highest-risk group, where broad screening is largely absent.
Paediatric care and radiation
A painless urine pre-screen helps clinicians decide when imaging is truly warranted, sparing children unnecessary radiation.
Universal coverage
One test across screened and unscreened cancers
IMUCEL is a frontline rule-in filter. A positive result supports faster referral, never a diagnosis on its own.
Talk to the IMUCEL team
For clinical collaboration, partnership, or press, we would like to hear from you.